Sosei enters into deal with FUJIFILM Pharma for commercialization of Loramyc in Japan
In May 2011, BioAlliance signed a licensing deal with Sosei to carry out bridging development program and commercialization rights in Japan for Loramyc in the treatment of oropharyngeal
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.